Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2
+
breast cancer cells
CA restores, at least in part, sensitivity to Tz in SKBR-3 Tz-resistant cell line.
»
11/03/17
The prevalence of DICER1 pathogenic variation in population databases.
Pathogenic DICER1 variation is more common than expected.
»
05/08/17
APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.
APELA, a small, secreted peptide, especially elevated in OCCC.
»
08/16/17
Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
Strong positive associations of balding status with serum testosterone.
»
07/14/17
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.
Quantification of CETCs could prove to be a prognostic marker.
»
10/28/17
Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
No clear association between duration from surgery to initiation of chemoradiation on OS.
»
04/05/17
Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a “sponge” against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells
MicroRNA-93 (miR-93) and Musashi-1 mediated the tumor suppression of LOCCS knockdown.
»
11/06/17
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas
TAGLN2 was induced ~ 2 to 3-fold by TGFβ2.
»
11/06/17
Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania
Recommended that receptor status assessment be made routine for breast cancer patients.
»
11/06/17
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines.
Treatment with different WIN 55,212-2 concentrations led to a significant dose-dependent reduction of cell viability.
»
08/09/17
< Prev
Next >